::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

SIGNIFICANT EFFECT OF LOWER GASTROINTESTINAL SYMPTOMS IN THE QUALITY OF LIFE AND GLYCEMIC CONTROL IN TYPE I DIABETES PATIENTS

AUTHORS:

Dr. Mohamed Mohamed, Dr. Abrar Wazzan*, Faisl Alslimah, Arwa Hakami, Asalah Alhazmi , Rawan Alhazmi , Azhar Alfaifi , Shaima Alzahrani , Afnan Madkhali , Lama Ayoub , Azhar Sowaidi , Afnan Maashi , Layla Mjrby , Bashaer Khormi ,Ahmed Alabdali

ABSTRACT:

Gastrointestinal symptoms are twice as common in type 1 diabetes and associated with poorer quality of life and glycemic control and quality of life. Lower gastrointestinal symptoms are not well characterized in people with type 1 diabetes, and the effects on quality of life and glycemic control has been studying. Gastrointestinal (GI) symptoms represent an important and often unappreciated cause of morbidity in diabetes, although the significance of this burden across the spectrum of patients and the underlying pathophysiology, including the relationship of symptoms with glycemic control, remain poorly defined. The relevance of GI symptoms and the necessity for their accurate assessment have increased with the greater focus on the gut as a therapeutic target for glucose lowering. This study aimed to determine the prevalence of lower gastrointestinal symptoms and the effects on glycemic control and quality of life, and to investigate for underlying causes. Keywords: Glycemic index, GI symptoms, diet, diabetes, quality of life.